Ovarioleukodystrophy due to EIF2B5 mutations

Richard Ibitoye, S Renowden, Howard Faulkner, Neil Scolding, Claire Rice

Research output: Contribution to journalArticle (Academic Journal)peer-review

11 Citations (Scopus)
418 Downloads (Pure)


Ovarioleukodystrophy – the co-occurrence of leukodystrophy and premature ovarian failure – is a rare presentation which is now recognised to be part of the clinical spectrum of vanishing white matter disease. We present the case of a lady with known seizures and neuroimaging changes consistent with leukoencephalopathy who presented with non-convulsive status epilepticus following initiation of hormone replacement therapy in the context of premature ovarian failure. Genetic testing confirmed she is a compound heterozygote for EIF2B-5 mutations; the gene encodes a subunit of eukaryotic translation initiation factor 2B. Mutations in EIF2B1-5 result in vanishing white matter disease. We highlight the importance of careful systemic review when investigating leukoencephalopathy and present a brief literature review of ovarioleukodystrophy.
Original languageEnglish
Pages (from-to)496-499
Number of pages4
JournalPractical Neurology
Issue number6
Early online date20 Sept 2016
Publication statusPublished - Dec 2016


  • EIF2B
  • VWM
  • ovarioleukodystrophy
  • vanishing white matter
  • epilepsy


Dive into the research topics of 'Ovarioleukodystrophy due to EIF2B5 mutations'. Together they form a unique fingerprint.

Cite this